NAMUSCLA 167 mg, gélules — plaquette(s) thermoformée(s) PVC PVDC aluminium de 100 gélule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930172148
  • CIP7 3017214
  • CIS 67638864
  • Registration number EU/1/18/1325

What the source publishes

Holder
LUPIN EUROPE (ALLEMAGNE)
Active ingredients
CHLORHYDRATE DE MEXILÉTINE, MEXILÉTINE
Form
gélule
Package
plaquette(s) thermoformée(s) PVC PVDC aluminium de 100 gélule(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription hospitalière ; liste I
Marketing status
Déclaration de commercialisation
Authorised on
2018-12-18
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930172148
{
  "cis": "67638864",
  "cip7": "3017214",
  "form": "gélule",
  "name": "NAMUSCLA 167 mg, gélules — plaquette(s) thermoformée(s) PVC PVDC aluminium de 100 gélule(s)",
  "cip13": "3400930172148",
  "holder": "LUPIN EUROPE (ALLEMAGNE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "LUPIN EUROPE (ALLEMAGNE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "2482.20",
  "authorisedOn": "2018-12-18",
  "compositions": [
    {
      "name": "CHLORHYDRATE DE MEXILÉTINE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "00924",
      "dosageReference": null,
      "pharmaceuticalElement": "gélule"
    },
    {
      "name": "MEXILÉTINE",
      "nature": "FT",
      "strength": "166,62 mg",
      "linkageNumber": "1",
      "substanceCode": "46355",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription hospitalière ; liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "2481.18",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "NAMUSCLA 167 mg, gélules",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-21",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) PVC PVDC aluminium de 100 gélule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2021-06-14",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "CHLORHYDRATE DE MEXILÉTINE",
    "MEXILÉTINE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription hospitalière",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/18/1325",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930172148"